Fox Run Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Fox Run Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,117	Closed	-$73K	–	538
2019 Q1	$73K	Sell	13,117 -5,083	-28%	-$30.9K	0.04%	430
2018 Q4	$121K	Sell	18,200 -7,009	-28%	-$56.8K	0.06%	456
2018 Q3	$269K	Sell	25,209 -13,066	-34%	-$150K	0.12%	385
2018 Q2	$459K	Sell	38,275 -6,998	-15%	-$71.6K	0.15%	280
2018 Q1	$388K	Buy	+45,273	New	+$419K	0.09%	403
2017 Q4	–	Sell	-30,600	Closed	-$376K	–	787
2017 Q3	$376K	Buy	+30,600	New	+$452K	0.11%	404
2017 Q2	–	Sell	-10,300	Closed	-$148K	–	735
2017 Q1	$148K	Sell	10,300 -11,900	-54%	-$177K	0.06%	516
2016 Q4	$307K	Buy	+22,200	New	+$356K	0.16%	279
2016 Q3	–	Sell	-19,100	Closed	-$274K	–	598
2016 Q2	$274K	Buy	+19,100	New	+$259K	0.13%	327

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

First Manhattan

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return